How it went for everyone who tried it
Helped means they said it helped with what they took it for, which may be one symptom and not the illness.
Shares are out of the 16 people who said how it went. 7 more tried it without saying how it went overall; 3 of them describe a problem.
| How it went | People | Share |
|---|---|---|
| Helped a lot | 3 | 19% |
| Helped | 3 | 19% |
| No change | 8 | 50% |
| Worse | 2 | 12% |
| Much worse | 0 | 0% |
| Where it was reported | Helped | Said how it went |
|---|---|---|
| 6 | 16 | |
| Recovery stories | 0 | 0 |
Did it last, for everyone it helped?
- None of the 6 people it helped said it wore off, whether or not they credit it for their improvement.
How it went for everyone who tried it
Helped means they said it helped with what they took it for, which may be one symptom and not the illness.
Shares are out of the 14 people who said how it went. 2 more tried it without saying how it went.
| How it went | People | Share |
|---|---|---|
| Helped a lot | 3 | 22% |
| Helped | 3 | 21% |
| No change | 6 | 43% |
| Worse | 2 | 14% |
| Much worse | 0 | 0% |
Shares are rounded to add up to 100, so two equal counts can show a point apart.
Did it last, for everyone it helped?
- None of the 6 people it helped said it wore off, whether or not they credit it for their improvement.
How it went for everyone who tried it
Helped means they said it helped with what they took it for, which may be one symptom and not the illness.
Shares are out of the 2 people who said how it went. 5 more tried it without saying how it went overall; 3 of them describe a problem.
| How it went | People | Share |
|---|---|---|
| Helped a lot | 0 | 0% |
| Helped | 0 | 0% |
| No change | 2 | 100% |
| Worse | 0 | 0% |
| Much worse | 0 | 0% |
| Where it was reported | Helped | Said how it went |
|---|---|---|
| 0 | 2 | |
| Recovery stories | 0 | 0 |
Ask about this treatment
Among the 4 who credit it with their improvement, here’s how they are now
Credit it means they say it’s one reason they got better: 3 say it helped them most; 1 says it was one of several things that helped.
Where each person was at the end of their story, or in their latest post that says how they are, compared with their worst point.
| Outcome described | People | Share |
|---|---|---|
| Recovered | 1 | 25% |
| Near normal | 0 | 0% |
| Much better | 1 | 25% |
| Somewhat better | 1 | 25% |
| Relapsed | 1 | 25% |
Did it last?
- No one said its benefit wore off.
- 2 of the 4 who credit it say they still need to keep doing something (not always this) to stay well.
Among the 4 who credit it with their improvement, here’s how they are now
Credit it means they say it’s one reason they got better: 3 say it helped them most; 1 says it was one of several things that helped.
Where each person was at the end of their story, or in their latest post that says how they are, compared with their worst point.
| Outcome described | People | Share |
|---|---|---|
| Recovered | 1 | 25% |
| Near normal | 0 | 0% |
| Much better | 1 | 25% |
| Somewhat better | 1 | 25% |
| Relapsed | 1 | 25% |
Did it last?
- No one said its benefit wore off.
- 2 of the 4 who credit it say they still need to keep doing something (not always this) to stay well.
No one with ME/CFS credits it with their improvement
Credit it means they say it’s one reason they got better.
Everyone · not split by condition
By how ill people were
Only the 4 who credit it, so people it didn’t help or made worse aren’t here. How they are now is their outcome overall, not the effect of this one treatment.
| Severity at worst | How they are now | n | Recovered or near normal |
|---|---|---|---|
| Moderate | 2 | 0%, few people | |
| Severe | 1 | 0%, few people | |
| Not stated | 1 | 100%, few people |
| At worst | Outcome | People | Share |
|---|---|---|---|
| Moderate | Much better | 1 of 2 | 50% |
| Moderate | Somewhat better | 1 of 2 | 50% |
| Severe | Relapsed | 1 of 1 | 100% |
| Not stated | Recovered | 1 of 1 | 100% |
Everyone · not split by condition
What people started next
10 of the 16 people who said how it went saw no change or got worse. 5 of those 10 say what they started next.
Everyone · not split by condition
Adverse events
What people said went wrong, in their own words.
6 of 23
people who wrote about taking it described a problem they tied to it
By kind
Unpleasant effects people tied to it, the most serious first.
Made symptoms worse · 2Side effects · 4 Show all 2Hide
Made symptoms worse
2 people“I got Evusheld. Really made my chest pain so much worse.”
— Glade 90539 “Happened again after I had Evusheld monoclonal antibodies a couple weeks ago, which had me freaked out all over again”
— Dove 71877 Side effects
4 people“And I received Evusheld A few days back. I felt ill the next day.”
— Rooney “The headache reminds me of how I felt for about a day after Evusheld (an old drug, a precursor to Pemgarda).”
— Osprey 22983 Show 2 moreShow fewer
“I only had a very slight cough and headache in the middle of the night. I received Evushield in March”
— Pebble 79863 “Got it Friday, slept all weekend.”
— Sparrow 58318
All posts · not split by condition
How often it comes up
Posts that mention Tixagevimab-cilgavimab (Evusheld), per 1,000 posts each month. Hover or tap a point for the count.
| Month | Posts mentioning it | All posts | Per 1,000 |
|---|---|---|---|
| Oct 2009 | 0 | 105 | 0 |
| Jan 2010 | 0 | 141 | 0 |
| Feb 2010 | 0 | 113 | 0 |
| Jun 2011 | 0 | 109 | 0 |
| Nov 2011 | 0 | 124 | 0 |
| Dec 2011 | 0 | 199 | 0 |
| Jan 2012 | 0 | 232 | 0 |
| Feb 2012 | 0 | 103 | 0 |
| Mar 2012 | 0 | 190 | 0 |
| Apr 2012 | 0 | 162 | 0 |
| May 2012 | 0 | 375 | 0 |
| Jun 2012 | 0 | 238 | 0 |
| Jul 2012 | 0 | 240 | 0 |
| Aug 2012 | 0 | 485 | 0 |
| Sep 2012 | 0 | 561 | 0 |
| Oct 2012 | 0 | 526 | 0 |
| Nov 2012 | 0 | 514 | 0 |
| Dec 2012 | 0 | 699 | 0 |
| Jan 2013 | 0 | 533 | 0 |
| Feb 2013 | 0 | 447 | 0 |
| Mar 2013 | 0 | 429 | 0 |
| Apr 2013 | 0 | 499 | 0 |
| May 2013 | 0 | 606 | 0 |
| Jun 2013 | 0 | 609 | 0 |
| Jul 2013 | 0 | 616 | 0 |
| Aug 2013 | 0 | 577 | 0 |
| Sep 2013 | 0 | 364 | 0 |
| Oct 2013 | 0 | 536 | 0 |
| Nov 2013 | 0 | 385 | 0 |
| Dec 2013 | 0 | 519 | 0 |
| Jan 2014 | 0 | 944 | 0 |
| Feb 2014 | 0 | 821 | 0 |
| Mar 2014 | 0 | 425 | 0 |
| Apr 2014 | 0 | 361 | 0 |
| May 2014 | 0 | 617 | 0 |
| Jun 2014 | 0 | 489 | 0 |
| Jul 2014 | 0 | 444 | 0 |
| Aug 2014 | 0 | 622 | 0 |
| Sep 2014 | 0 | 507 | 0 |
| Oct 2014 | 0 | 678 | 0 |
| Nov 2014 | 0 | 567 | 0 |
| Dec 2014 | 0 | 629 | 0 |
| Jan 2015 | 0 | 760 | 0 |
| Feb 2015 | 0 | 873 | 0 |
| Mar 2015 | 0 | 1,276 | 0 |
| Apr 2015 | 0 | 984 | 0 |
| May 2015 | 0 | 1,496 | 0 |
| Jun 2015 | 0 | 1,046 | 0 |
| Jul 2015 | 0 | 1,211 | 0 |
| Aug 2015 | 0 | 998 | 0 |
| Sep 2015 | 0 | 1,060 | 0 |
| Oct 2015 | 0 | 1,255 | 0 |
| Nov 2015 | 0 | 1,246 | 0 |
| Dec 2015 | 0 | 924 | 0 |
| Jan 2016 | 0 | 1,282 | 0 |
| Feb 2016 | 0 | 1,051 | 0 |
| Mar 2016 | 0 | 1,002 | 0 |
| Apr 2016 | 0 | 998 | 0 |
| May 2016 | 0 | 1,045 | 0 |
| Jun 2016 | 0 | 1,230 | 0 |
| Jul 2016 | 0 | 1,619 | 0 |
| Aug 2016 | 0 | 1,729 | 0 |
| Sep 2016 | 0 | 1,785 | 0 |
| Oct 2016 | 0 | 1,220 | 0 |
| Nov 2016 | 0 | 1,092 | 0 |
| Dec 2016 | 0 | 1,211 | 0 |
| Jan 2017 | 0 | 1,660 | 0 |
| Feb 2017 | 0 | 1,988 | 0 |
| Mar 2017 | 0 | 2,078 | 0 |
| Apr 2017 | 0 | 2,133 | 0 |
| May 2017 | 0 | 2,370 | 0 |
| Jun 2017 | 0 | 2,194 | 0 |
| Jul 2017 | 0 | 2,183 | 0 |
| Aug 2017 | 0 | 2,466 | 0 |
| Sep 2017 | 0 | 2,189 | 0 |
| Oct 2017 | 0 | 3,042 | 0 |
| Nov 2017 | 0 | 1,976 | 0 |
| Dec 2017 | 0 | 2,112 | 0 |
| Jan 2018 | 0 | 2,620 | 0 |
| Feb 2018 | 0 | 2,155 | 0 |
| Mar 2018 | 0 | 2,613 | 0 |
| Apr 2018 | 0 | 2,251 | 0 |
| May 2018 | 0 | 2,828 | 0 |
| Jun 2018 | 0 | 3,871 | 0 |
| Jul 2018 | 0 | 3,067 | 0 |
| Aug 2018 | 0 | 3,757 | 0 |
| Sep 2018 | 0 | 3,512 | 0 |
| Oct 2018 | 0 | 3,261 | 0 |
| Nov 2018 | 0 | 2,861 | 0 |
| Dec 2018 | 0 | 2,754 | 0 |
| Jan 2019 | 0 | 3,672 | 0 |
| Feb 2019 | 0 | 2,715 | 0 |
| Mar 2019 | 0 | 3,317 | 0 |
| Apr 2019 | 0 | 3,141 | 0 |
| May 2019 | 0 | 3,855 | 0 |
| Jun 2019 | 0 | 3,392 | 0 |
| Jul 2019 | 0 | 3,312 | 0 |
| Aug 2019 | 0 | 3,943 | 0 |
| Sep 2019 | 0 | 4,035 | 0 |
| Oct 2019 | 0 | 3,922 | 0 |
| Nov 2019 | 0 | 3,508 | 0 |
| Dec 2019 | 0 | 3,659 | 0 |
| Jan 2020 | 0 | 4,650 | 0 |
| Feb 2020 | 0 | 4,374 | 0 |
| Mar 2020 | 0 | 4,475 | 0 |
| Apr 2020 | 0 | 3,690 | 0 |
| May 2020 | 0 | 4,543 | 0 |
| Jun 2020 | 0 | 5,701 | 0 |
| Jul 2020 | 0 | 6,104 | 0 |
| Aug 2020 | 0 | 10,333 | 0 |
| Sep 2020 | 0 | 11,958 | 0 |
| Oct 2020 | 0 | 14,568 | 0 |
| Nov 2020 | 0 | 16,546 | 0 |
| Dec 2020 | 0 | 20,764 | 0 |
| Jan 2021 | 0 | 24,562 | 0 |
| Feb 2021 | 0 | 24,672 | 0 |
| Mar 2021 | 0 | 29,476 | 0 |
| Apr 2021 | 0 | 28,509 | 0 |
| May 2021 | 0 | 25,791 | 0 |
| Jun 2021 | 0 | 27,871 | 0 |
| Jul 2021 | 0 | 27,220 | 0 |
| Aug 2021 | 0 | 30,808 | 0 |
| Sep 2021 | 0 | 30,074 | 0 |
| Oct 2021 | 0 | 22,132 | 0 |
| Nov 2021 | 0 | 27,722 | 0 |
| Dec 2021 | 0 | 31,872 | 0 |
| Jan 2022 | 2 | 42,317 | 0.05 |
| Feb 2022 | 0 | 38,697 | 0 |
| Mar 2022 | 2 | 44,305 | 0.05 |
| Apr 2022 | 9 | 44,333 | 0.20 |
| May 2022 | 3 | 50,594 | 0.06 |
| Jun 2022 | 7 | 49,058 | 0.14 |
| Jul 2022 | 6 | 53,485 | 0.11 |
| Aug 2022 | 1 | 54,455 | 0.02 |
| Sep 2022 | 1 | 56,936 | 0.02 |
| Oct 2022 | 8 | 58,511 | 0.14 |
| Nov 2022 | 2 | 59,198 | 0.03 |
| Dec 2022 | 1 | 61,576 | 0.02 |
| Jan 2023 | 2 | 61,004 | 0.03 |
| Feb 2023 | 4 | 50,133 | 0.08 |
| Mar 2023 | 1 | 59,925 | 0.02 |
| Apr 2023 | 1 | 54,251 | 0.02 |
| May 2023 | 1 | 57,768 | 0.02 |
| Jun 2023 | 6 | 52,679 | 0.11 |
| Jul 2023 | 5 | 56,401 | 0.09 |
| Aug 2023 | 3 | 65,435 | 0.05 |
| Sep 2023 | 10 | 61,835 | 0.16 |
| Oct 2023 | 3 | 58,419 | 0.05 |
| Nov 2023 | 0 | 53,662 | 0 |
| Dec 2023 | 5 | 60,643 | 0.08 |
| Jan 2024 | 8 | 71,818 | 0.11 |
| Feb 2024 | 0 | 70,045 | 0 |
| Mar 2024 | 5 | 68,261 | 0.07 |
| Apr 2024 | 11 | 64,374 | 0.17 |
| May 2024 | 0 | 67,698 | 0 |
| Jun 2024 | 0 | 64,720 | 0 |
| Jul 2024 | 2 | 65,335 | 0.03 |
| Aug 2024 | 5 | 68,517 | 0.07 |
| Sep 2024 | 2 | 70,168 | 0.03 |
| Oct 2024 | 1 | 72,607 | 0.01 |
| Nov 2024 | 4 | 71,802 | 0.06 |
| Dec 2024 | 13 | 74,401 | 0.17 |
| Jan 2025 | 12 | 77,909 | 0.15 |
| Feb 2025 | 27 | 65,110 | 0.41 |
| Mar 2025 | 9 | 69,905 | 0.13 |
| Apr 2025 | 3 | 61,606 | 0.05 |
| May 2025 | 2 | 65,733 | 0.03 |
| Jun 2025 | 1 | 60,540 | 0.02 |
| Jul 2025 | 2 | 62,105 | 0.03 |
| Aug 2025 | 3 | 64,578 | 0.05 |
| Sep 2025 | 0 | 61,704 | 0 |
| Oct 2025 | 1 | 59,204 | 0.02 |
| Nov 2025 | 0 | 58,944 | 0 |
| Dec 2025 | 0 | 62,830 | 0 |
| Jan 2026 | 0 | 63,321 | 0 |
| Feb 2026 | 0 | 53,085 | 0 |
| Mar 2026 | 0 | 59,208 | 0 |
| Apr 2026 | 0 | 53,989 | 0 |
| May 2026 | 0 | 57,541 | 0 |
| Jun 2026 | 0 | 55,301 | 0 |
| Jul 2026 | 0 | 56,391 | 0 |
| Aug 2026 | 0 | 56,825 | 0 |
| Sep 2026 | 0 | 57,143 | 0 |
Forum and Reddit posts, 4,007,898 in all, counted per month. A mention means the post names the treatment, not that the writer took it. All trends
20 of the 23 people who tried it
See all 23 stories-
Long COVID with crashes, now much better after low-dose naltrexone and Evusheld/Paxlovid
Crane 85895, in the UK, developed long COVID after a second reinfection around 2022 (they recovered from their first infection in 2020). Supplements and the IncellDX protocol helped symptoms; low-dose naltrexone, started December 2023 and built to 9 mg, made…
-
Long COVID with POTS and MCAS; improved 70% on antibodies, then reinfection relapse
Osprey 22983 developed long COVID after a COVID infection in late 2021, with POTS, MCAS, breathlessness and gut problems. Off-label IV monoclonal antibodies and more frequent Evusheld doses improved them by about 70%, a gain they call life-changing. A…
-
Long COVID fever for two and a half years, now recovered after Evusheld and Paxlovid
Spruce 87221 had long COVID with a low-grade fever that came and went for about two and a half years, plus other symptoms. A few courses of long-acting monoclonal antibodies (Evusheld) and Paxlovid in combination: the first reduced the fever and other…
-
Unable to work much for 10 months with ME/CFS, somewhat better with vitamin C and Cortef
A US patient on the ME/CFS spectrum tipped into CFS after travel vaccinations and a later flu shot around 2019, and was able to return to work after a first bad vaccine reaction before a second reaction left them unable to work much for about 10 months.…
-
Long COVID left them mostly horizontal, now much better after triple anticoagulant therapy
Comet 62464 got long COVID after a February 2023 infection and was soon spending most of the day horizontal, with breathlessness, gut pain, neuropathy, what they thought might be POTS, and muscle fatigue/extreme PEM. Triple anticoagulant therapy from May…
-
Bedridden with long COVID, now nearly back to normal on maraviroc and Rinvoq
A second COVID infection in July 2024 led to PEM, fatigue, aches, neuropathy and double vision a month later, plus POTS-like symptoms; they became bedridden with pain, malaise and fatigue and lost weight from 220 to 162 lbs. A Pfizer booster left them worse…
-
Recliner-bound with ME/CFS, now much better after POTS drugs and strict pacing
Hill 69287 fell ill at 32 and became recliner-bound, able to speak only a few words a day. She credits POTS drugs, hydrocortisone for adrenal dysfunction, MCAS treatment, low-dose naltrexone and strict pacing for partial recovery; pregnancy at 39 also…
-
Daily headaches and POTS with long COVID, now much better on beta blockers and LDN
A 37-year-old in Southern California had mild COVID-19 in March 2020, recovered, then relapsed in June with daily headaches starting July 2020 that persisted after a brief break. Pfizer shots in 2021 brought POTS, palpitations and worse headaches, later…
-
Colostrum Maf
Rooney described 23 years of ME/CFS after a sudden viral onset, with POTS, fibromyalgia, SIBO and headaches, and rated themselves moderate in severity. B12 injections and folate stopped hand tremors and headaches and methylation eased a poisoned feeling, but…
-
Bedbound or housebound with long COVID, somewhat better after breathing exercises and pacing
Cardinal 45128 caught covid in February 2020 and spent long stretches bedbound or housebound with fatigue, flu-like symptoms, fever and air hunger. Breathing exercises cleared the air hunger; pacing, cold plunges, fasting and nattokinase gave slow gains…
-
Long COVID with dizziness, nausea and breathlessness, now recovered after fludrocortisone
She developed long COVID with dizziness, nausea, breathlessness, orthostatic hypotension and word-finding problems. A physician's assistant diagnosed orthostatic hypotension and prescribed fludrocortisone, which began helping within days; she also drank…
-
Long COVID with brutal fatigue, malaise and body pain, now about 90% better on baricitinib
A Reddit user with long COVID/ME/CFS reported brutal fatigue, malaise and body pain and had tried dozens of drugs. Saphnello (for lupus) made them feel like a new person, but maraviroc plus pravastatin caused a severe inflammatory flare and rash, calmed by…
-
Housebound with long COVID, now somewhat better with HBOT and cetirizine
Badger 52177 caught COVID in March 2020 and became severe, housebound and mostly in bed, with fatigue, PEM, constant headaches and severe insomnia. About eight months in, hyperbaric oxygen therapy stopped the decline and they improved slowly to moderate,…
-
Long COVID vertigo made crawling hard; somewhat better with steroids and PT
Dew 12173 developed long COVID after COVID in September 2022 and a second infection six weeks later, with vertigo, palpitations, tremors, brain fog and night sweats. Vertigo was by far the most debilitating symptom, sometimes leaving them unable to orient…
-
Nearly bedbound with ME/CFS, now some improvement after low-dose Abilify and mould removal
ME/CFS began gradually in their teens, and a presumed COVID infection in March 2020 pushed them from remission to moderate-severe; mRNA vaccination in 2021 brought on POTS and dysautonomia. By 2023 they were nearly bedbound and using a wheelchair. Low-dose…
-
Long COVID brain fog and chronic cough, now nearly back to normal after second Pfizer dose
Canyon 92534 had a probable COVID infection in January 2020, with initial loss of taste and smell, and developed long COVID: thick brain fog and a chronic cough, while still working in tech. A second Pfizer dose in February 2021 lifted the brain fog…
-
Immunocompromised with long COVID, still living like a monk and stressing N95s
Quail 34927 describes themselves as immunocompromised and a very poor vaccine responder. Although they had Evusheld, they still caught a nasty BA2 COVID infection. They still live 'like a monk' and stress that a well-fitted N95 or equivalent is vital, and…
-
Severe ME/CFS, now back to moderate but mostly housebound, after migraine drugs and pacing
Stone 73320 fell ill with COVID in March 2020, aged 30, and had ME/CFS-type symptoms from day two. Two Pfizer doses in 2021 tipped her from moderate to severe; she spent a year in the dark, struggling to speak or tolerate light. CGRP migraine drugs, nerve…
-
Long COVID with daily panic attacks, improved then relapsed; credits Regeneron and NAC
Prairie 39511 caught COVID in the 2021 delta wave and had long COVID for about a year, with daily panic attacks that sent them to the ER. They credited Regeneron during the acute infection with saving their life and NAC with helping; Paxil caused…
-
Long COVID brain fog, word-finding trouble and autoimmune disorders, now somewhat better
A Reddit user who caught COVID in May 2020 and again in December 2021 despite vaccination developed long COVID with word-finding trouble and regular brain fog and, they said, two autoimmune disorders. The word-finding eased about two months after they got…
These are the newest 3 of the 4 who credit Tixagevimab-cilgavimab (Evusheld) for their improvement, then the newest 17 of the 19 who tried it without crediting it, in about the same proportion as the full list.
All 16 people who tried it
-
Long COVID with crashes, now much better after low-dose naltrexone and Evusheld/Paxlovid
Crane 85895, in the UK, developed long COVID after a second reinfection around 2022 (they recovered from their first infection in 2020). Supplements and the IncellDX protocol helped symptoms; low-dose naltrexone, started December 2023 and built to 9 mg, made…
-
Long COVID with POTS and MCAS; improved 70% on antibodies, then reinfection relapse
Osprey 22983 developed long COVID after a COVID infection in late 2021, with POTS, MCAS, breathlessness and gut problems. Off-label IV monoclonal antibodies and more frequent Evusheld doses improved them by about 70%, a gain they call life-changing. A…
-
Long COVID fever for two and a half years, now recovered after Evusheld and Paxlovid
Spruce 87221 had long COVID with a low-grade fever that came and went for about two and a half years, plus other symptoms. A few courses of long-acting monoclonal antibodies (Evusheld) and Paxlovid in combination: the first reduced the fever and other…
-
Long COVID and barely able to climb stairs, somewhat better after Evusheld
Sandpiper 66396 had rheumatoid arthritis and asthma before catching COVID-19 twice in 2022, which left them with long COVID and barely able to climb a flight of stairs. An Evusheld monoclonal antibody infusion in a trial brought them to halfway functional…
-
Long COVID left them mostly horizontal, now much better after triple anticoagulant therapy
Comet 62464 got long COVID after a February 2023 infection and was soon spending most of the day horizontal, with breathlessness, gut pain, neuropathy, what they thought might be POTS, and muscle fatigue/extreme PEM. Triple anticoagulant therapy from May…
-
Bedridden with long COVID, now nearly back to normal on maraviroc and Rinvoq
A second COVID infection in July 2024 led to PEM, fatigue, aches, neuropathy and double vision a month later, plus POTS-like symptoms; they became bedridden with pain, malaise and fatigue and lost weight from 220 to 162 lbs. A Pfizer booster left them worse…
-
Daily headaches and POTS with long COVID, now much better on beta blockers and LDN
A 37-year-old in Southern California had mild COVID-19 in March 2020, recovered, then relapsed in June with daily headaches starting July 2020 that persisted after a brief break. Pfizer shots in 2021 brought POTS, palpitations and worse headaches, later…
-
Bedbound or housebound with long COVID, somewhat better after breathing exercises and pacing
Cardinal 45128 caught covid in February 2020 and spent long stretches bedbound or housebound with fatigue, flu-like symptoms, fever and air hunger. Breathing exercises cleared the air hunger; pacing, cold plunges, fasting and nattokinase gave slow gains…
-
Long COVID with dizziness, nausea and breathlessness, now recovered after fludrocortisone
She developed long COVID with dizziness, nausea, breathlessness, orthostatic hypotension and word-finding problems. A physician's assistant diagnosed orthostatic hypotension and prescribed fludrocortisone, which began helping within days; she also drank…
-
Long COVID with brutal fatigue, malaise and body pain, now about 90% better on baricitinib
A Reddit user with long COVID/ME/CFS reported brutal fatigue, malaise and body pain and had tried dozens of drugs. Saphnello (for lupus) made them feel like a new person, but maraviroc plus pravastatin caused a severe inflammatory flare and rash, calmed by…
-
Housebound with long COVID, now somewhat better with HBOT and cetirizine
Badger 52177 caught COVID in March 2020 and became severe, housebound and mostly in bed, with fatigue, PEM, constant headaches and severe insomnia. About eight months in, hyperbaric oxygen therapy stopped the decline and they improved slowly to moderate,…
-
Long COVID vertigo made crawling hard; somewhat better with steroids and PT
Dew 12173 developed long COVID after COVID in September 2022 and a second infection six weeks later, with vertigo, palpitations, tremors, brain fog and night sweats. Vertigo was by far the most debilitating symptom, sometimes leaving them unable to orient…
-
Long COVID brain fog and chronic cough, now nearly back to normal after second Pfizer dose
Canyon 92534 had a probable COVID infection in January 2020, with initial loss of taste and smell, and developed long COVID: thick brain fog and a chronic cough, while still working in tech. A second Pfizer dose in February 2021 lifted the brain fog…
-
Immunocompromised with long COVID, still living like a monk and stressing N95s
Quail 34927 describes themselves as immunocompromised and a very poor vaccine responder. Although they had Evusheld, they still caught a nasty BA2 COVID infection. They still live 'like a monk' and stress that a well-fitted N95 or equivalent is vital, and…
-
Long COVID with daily panic attacks, improved then relapsed; credits Regeneron and NAC
Prairie 39511 caught COVID in the 2021 delta wave and had long COVID for about a year, with daily panic attacks that sent them to the ER. They credited Regeneron during the acute infection with saving their life and NAC with helping; Paxil caused…
-
Long COVID brain fog, word-finding trouble and autoimmune disorders, now somewhat better
A Reddit user who caught COVID in May 2020 and again in December 2021 despite vaccination developed long COVID with word-finding trouble and regular brain fog and, they said, two autoimmune disorders. The word-finding eased about two months after they got…
The first 4 credit Tixagevimab-cilgavimab (Evusheld) for their improvement; the other 12 tried it without crediting it.
All 7 people who tried it
-
Unable to work much for 10 months with ME/CFS, somewhat better with vitamin C and Cortef
A US patient on the ME/CFS spectrum tipped into CFS after travel vaccinations and a later flu shot around 2019, and was able to return to work after a first bad vaccine reaction before a second reaction left them unable to work much for about 10 months.…
-
Recliner-bound with ME/CFS, now much better after POTS drugs and strict pacing
Hill 69287 fell ill at 32 and became recliner-bound, able to speak only a few words a day. She credits POTS drugs, hydrocortisone for adrenal dysfunction, MCAS treatment, low-dose naltrexone and strict pacing for partial recovery; pregnancy at 39 also…
-
Colostrum Maf
Rooney described 23 years of ME/CFS after a sudden viral onset, with POTS, fibromyalgia, SIBO and headaches, and rated themselves moderate in severity. B12 injections and folate stopped hand tremors and headaches and methylation eased a poisoned feeling, but…
-
Nearly bedbound with ME/CFS, now some improvement after low-dose Abilify and mould removal
ME/CFS began gradually in their teens, and a presumed COVID infection in March 2020 pushed them from remission to moderate-severe; mRNA vaccination in 2021 brought on POTS and dysautonomia. By 2023 they were nearly bedbound and using a wheelchair. Low-dose…
-
Severe ME/CFS, now back to moderate but mostly housebound, after migraine drugs and pacing
Stone 73320 fell ill with COVID in March 2020, aged 30, and had ME/CFS-type symptoms from day two. Two Pfizer doses in 2021 tipped her from moderate to severe; she spent a year in the dark, struggling to speak or tolerate light. CGRP migraine drugs, nerve…
-
With ME/CFS, only a slight cough and headache after Evushield
Pebble 79863, a Reddit user in an ME/CFS forum, received the monoclonal antibody Evushield in March and reported only a very slight cough and headache in the middle of the night afterwards. They wondered whether other recipients of the shot also felt sick…
-
ME/CFS, got something on a Friday and slept all weekend afterwards
A person in an ME/CFS community said they got something on a Friday and slept all weekend afterwards. They did not say when their illness began, how severe it was at baseline, what symptoms they had, what other treatments they tried or how they were doing…
None of them credit Tixagevimab-cilgavimab (Evusheld) for their improvement.